Cardiex Limited

Home
Australia
Sydney, NSW
Cardiex Limited

Cardiex is a health technology company specializing in digital biomarkers for monitoring vascular health. ASX:CQT

15/10/2025

Cardiex is now CONNEQT Health.

Driving the future of arterial health.

We’ve brought together our mission, team, and technology to deliver innovation across home, clinical, and research settings. The result is more personalized, proactive care for every stage of cardiovascular health.

We’re shaping the future of cardiovascular care through Arterial Intelligence™.

🔗 Follow on your favorite platform:
Instagram | Facebook | X | LinkedIn | YouTube

📍 Now trading on the ASX as CQT

Conneqt Health

29/09/2025

A New Era in Arterial Health

Cardiex is now CONNEQT Health.

One name. One mission. One vision for the future of arterial health.

We’re uniting our mission and innovation under a single name as we build the first connected ecosystem for arterial health.

This change brings clarity to our platform, strengthens our identity, and reflects the growing momentum of our Pulse arterial health monitor across homes, clinics, and research.

It’s more than a name change. It’s a step forward in making proactive, personalized cardiovascular care more accessible than ever.

📰 Read the full announcement:https://announcements.asx.com.au/asxpdf/20250923/pdf/06pk0f90bw0y8n.pdf

$CQT Conneqt Health

26/04/2023

CardieX (ASX:CDX) subsidiary CONNEQT Health has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) for the CONNEQT Pulse, a world-first vascular biometric monitor that provides both brachial and central blood pressure measurements along with multiple other biometric parameters not available in traditional blood pressure monitors.

CardieX CEO, Craig Cooper, commented: “CONNEQT Pulse’s 510(k) clearance by the FDA marks a major milestone in the field of cardiovascular health management. We’re thrilled to offer individuals with hypertension and other vascular diseases an innovative new way to monitor their arterial health at home with the same tools the country’s top cardiologists use in their research facilities and clinics. At launch, there won’t be any other vital signs monitor that provides the level of features, personalization, or vascular health insights that will be available on the Pulse. This technology has the potential to truly revolutionize the way hypertension and vascular disease are diagnosed and managed in the future.”

Read the full story here: https://tinyurl.com/2y7pdu2p

Address

Sydney, NSW

Website

https://cardiex.com/

Alerts

Be the first to know and let us send you an email when Cardiex Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.